XML 123 R114.htm IDEA: XBRL DOCUMENT v3.25.0.1
SEGMENT INFORMATION - Profitability (Details)
$ in Millions
 12 Months Ended
Oct. 31, 2024
USD ($)
segment
Oct. 31, 2023
USD ($)
segment
Oct. 31, 2022
USD ($)
segment
Segment Reporting [Abstract]      
Number of operating segments | segment 3 3 3
Select income statement components      
Net revenue $ 6,510 $ 6,833 $ 6,848
Income from operations 1,488 1,350 1,618
Share-based compensation expense 130 112 126
Depreciation expense $ 149 $ 128 $ 120
Number of operating segments | segment 3 3 3
Operating Segments      
Select income statement components      
Income from operations $ 1,721 $ 1,875 $ 1,857
Segment Reporting, Reconciling Item, Corporate Nonsegment      
Select income statement components      
Share-based compensation expense 12 0 6
Life Sciences and Diagnostics Markets      
Select income statement components      
Net revenue 2,466 2,780 2,844
Life Sciences and Diagnostics Markets | Operating Segments      
Select income statement components      
Net revenue 2,466 2,780 2,844
Income from operations 484 673 711
Share-based compensation expense 46 48 52
Depreciation expense 72 60 57
Agilent CrossLab      
Select income statement components      
Net revenue 2,747 2,656 2,563
Agilent CrossLab | Operating Segments      
Select income statement components      
Net revenue 2,747 2,656 2,563
Income from operations 925 839 779
Share-based compensation expense 48 40 43
Depreciation expense 54 46 42
Applied Markets      
Select income statement components      
Net revenue 1,297 1,397 1,441
Applied Markets | Operating Segments      
Select income statement components      
Net revenue 1,297 1,397 1,441
Income from operations 312 363 367
Share-based compensation expense 24 24 25
Depreciation expense $ 23 $ 22 $ 21